CorMatrix ECM Technology has been used at more than 500 hospitals across the U.S. and has been implanted in nearly 40,000 cardiac procedures.
This naturally occurring extracellular matrix biomaterial supports native tissue repair by providing an interim bioscaffold, that enables a patient's own cells to repopulate and repair damaged tissues.



